These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32190729)

  • 1. Stable Monomeric Insulin Formulations Enabled by Supramolecular PEGylation of Insulin Analogues.
    Maikawa CL; Smith AAA; Zou L; Meis CM; Mann JL; Webber MJ; Appel EA
    Adv Ther (Weinh); 2020 Jan; 3(1):. PubMed ID: 32190729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation Excipients and Their Role in Insulin Stability and Association State in Formulation.
    Maikawa CL; Nguyen LT; Mann JL; Appel EA
    Pharm Res; 2022 Nov; 39(11):2721-2728. PubMed ID: 35978148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ultrafast insulin formulation enabled by high-throughput screening of engineered polymeric excipients.
    Mann JL; Maikawa CL; Smith AAA; Grosskopf AK; Baker SW; Roth GA; Meis CM; Gale EC; Liong CS; Correa S; Chan D; Stapleton LM; Yu AC; Muir B; Howard S; Postma A; Appel EA
    Sci Transl Med; 2020 Jul; 12(550):. PubMed ID: 32611683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
    Ilag LL; Kerr L; Malone JK; Tan MH
    Clin Ther; 2007 Jun; 29(6 Pt 1):1254-70. PubMed ID: 18036388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
    Ilag LL; Kerr L; Malone JK; Tan MH
    Clin Ther; 2007; 29 Spec No():1254-70. PubMed ID: 18046926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of phenol and meta-cresol depletion on insulin analog stability at physiological temperature.
    Teska BM; Alarcón J; Pettis RJ; Randolph TW; Carpenter JF
    J Pharm Sci; 2014 Aug; 103(8):2255-67. PubMed ID: 24909933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ultrafast-acting insulin analogues in the management of diabetes.
    Kruger DF; Novak LM
    J Am Assoc Nurse Pract; 2019 Sep; 31(9):537-548. PubMed ID: 31385938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supramolecular approaches for insulin stabilization without prolonged duration of action.
    Meudom R; Zhang Y; VandenBerg MA; Zou L; Zhang YW; Webber MJ; Chou DH
    Acta Pharm Sin B; 2023 May; 13(5):2281-2290. PubMed ID: 37250160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable High-Concentration Monoclonal Antibody Formulations Enabled by an Amphiphilic Copolymer Excipient.
    Klich JH; Kasse CM; Mann JL; Huang Y; d'Aquino AI; Grosskopf AK; Baillet J; Fuller GG; Appel EA
    Adv Ther (Weinh); 2023 Jan; 6(1):. PubMed ID: 36684707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra-Fast Insulin-Pramlintide Co-Formulation for Improved Glucose Management in Diabetic Rats.
    Maikawa CL; Chen PC; Vuong ET; Nguyen LT; Mann JL; d'Aquino AI; Lal RA; Maahs DM; Buckingham BA; Appel EA
    Adv Sci (Weinh); 2021 Nov; 8(21):e2101575. PubMed ID: 34499434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous insulin absorption explained by insulin's physicochemical properties. Evidence from absorption studies of soluble human insulin and insulin analogues in humans.
    Kang S; Brange J; Burch A; Vølund A; Owens DR
    Diabetes Care; 1991 Nov; 14(11):942-8. PubMed ID: 1797506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling Insulin Oligomeric States by
    Falk BT; Liang Y; McCoy MA
    J Pharm Sci; 2020 Jan; 109(1):922-926. PubMed ID: 31449814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic fibrillation of fast-acting insulin analogs.
    Woods RJ; Alarcón J; McVey E; Pettis RJ
    J Diabetes Sci Technol; 2012 Mar; 6(2):265-76. PubMed ID: 22538135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the value of faster acting prandial insulin? Focus on ultra rapid lispro.
    Heise T; Piras de Oliveira C; Juneja R; Ribeiro A; Chigutsa F; Blevins T
    Diabetes Obes Metab; 2022 Sep; 24(9):1689-1701. PubMed ID: 35593434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premixed insulin treatment for type 2 diabetes: analogue or human?
    Garber AJ; Ligthelm R; Christiansen JS; Liebl A
    Diabetes Obes Metab; 2007 Sep; 9(5):630-9. PubMed ID: 17697056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The continuing quest for better subcutaneously administered prandial insulins: a review of recent developments and potential clinical implications.
    Owens DR; Bolli GB
    Diabetes Obes Metab; 2020 May; 22(5):743-754. PubMed ID: 31930670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premixed insulin analogues for the treatment of diabetes mellitus.
    Garber AJ
    Drugs; 2006; 66(1):31-49. PubMed ID: 16398567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photoacoustic imaging reveals mechanisms of rapid-acting insulin formulations dynamics at the injection site.
    Khadria A; Paavola CD; Maslov K; Valenzuela FA; Sperry AE; Cox AL; Cao R; Shi J; Brown-Augsburger PL; Lozano E; Blankenship RL; Majumdar R; Bradley SA; Beals JM; Oladipupo SS; Wang LV
    Mol Metab; 2022 Aug; 62():101522. PubMed ID: 35671972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast-Acting Insulin Aspart and the Need for New Mealtime Insulin Analogues in Adults With Type 1 and Type 2 Diabetes: A Canadian Perspective.
    Senior P; Hramiak I
    Can J Diabetes; 2019 Oct; 43(7):515-523. PubMed ID: 30872107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of a family of ultra-rapid-acting insulins: formulation development.
    Krasner A; Pohl R; Simms P; Pichotta P; Hauser R; De Souza E
    J Diabetes Sci Technol; 2012 Jul; 6(4):786-96. PubMed ID: 22920803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.